comparemela.com

Latest Breaking News On - இந்தியன் நிறுவனம் ஆஃப் அறிவியல் இஸ்க் பெங்களூரு - Page 1 : comparemela.com

IISc-Bengaluru s warm COVID vaccine powerful against all significant variants of concern: Study

Date: 16 Jul,2021 A heat-tolerant COVID-19 vaccine formulation developed by the Indian Institute of Science (IISc) Bengaluru has proven effective against all current SARS-CoV-2 variants of concern, according to a study in animals. The research, published in the ACS Infectious Diseases journal on Thursday, showed the vaccine formulations by IISc-incubated biotech start-up Mynvax triggered a strong immune response in mice. The formulation also protected hamsters from the virus and remained stable at 37 degrees Celsius up to a month, and at 100 degrees Celsius for up to 90 minutes, the researchers said. The team, including researchers from Australia’s Commonwealth Scientific and Industrial Research Organisation (CSIRO), noted that most vaccines require refrigeration to remain effective.

IISc s warm COVID-19 vaccine effective against all major variants: Study

It remained stable at 37 degrees Celsius for a month The formulation also protected hamsters from the deadly virus and remained stable at 37 degrees Celsius for up to a month, and at 100 degrees Celsius for up to 90 minutes, the researchers said. The team, including researchers from Australia s Commonwealth Scientific and Industrial Research Organization (CSIRO), noted that most vaccines require refrigeration to remain effective. Information Almost all other vaccines require refrigeration For example, the Oxford-AstraZeneca vaccine, known as Covishield in India, must be kept between 2-8 degrees Celsius and the Pfizer preventive requires specialized cold storage at minus 70 degrees Celsius. Response All formulations of Mynvax result in antibodies: Co-author

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.